Clearside Biomedical Inc. (CLSD) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Clearside Biomedical Inc.

NASDAQ: CLSD · Real-Time Price · USD
4.37
0.30 (7.37%)
At close: Oct 03, 2025, 3:59 PM
4.29
-1.83%
After-hours: Oct 03, 2025, 07:30 PM EDT

Clearside Biomedical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-27.71M -30.81M -34.35M -31.88M -33.46M -34.97M -32.48M -37.32M -35.88M -34.58M -32.95M -4.58M -1.64M 83K 376K -25.45M -22.99M -22.65M
Depreciation & Amortization
323K 283K 226K 167K 108K 80K 67K 69K 92K 114K 145K 168K 173K 179K 178K 177K 179K 180K
Stock-Based Compensation
3.75M 4.17M 4.51M 4.37M 4.28M 4.22M 4.2M 4.33M 4.33M 4.62M 4.88M 4.99M 5.23M 5.21M 5.05M 4.67M 4.19M 3.75M
Other Working Capital
-1.87M -1.37M -244K 456K 532K 228K -961K -2.16M -814.42K -1.38M 10.63M 5.42M 5.6M 3.83M -6.78M 658K -706K 2.96M
Other Non-Cash Items
5.88M 5.16M 6.59M 8.83M 9.53M 11.52M 9.78M 9.1M 7.58M 5.28M 3.12M -14.25M -15.34M -15.34M -16.34M 124K 124K 281K
Deferred Income Tax
n/a n/a n/a -419K -419K -419K -419K n/a n/a 1K 1K 15.34M 15.34M 15.34M 15.34M -1.12M -1.12M -1.12M
Change in Working Capital
-3.97M -1.48M -1.68M -20K 840K 799K 720K -418K -667K -85K 11.24M -4.58M -3.56M -6.77M -15.34M 1.38M 11K 3.68M
Operating Cash Flow
-21.73M -22.68M -24.7M -18.95M -19.11M -18.77M -18.14M -24.24M -24.35M -24.45M -13.37M -2.7M 204K -1.3M -10.73M -20.22M -19.61M -15.88M
Capital Expenditures
-506K -929K -977K -653K -1.04M -1.72M -1.78M -1.75M -1.46M -361K -246K -155K n/a n/a n/a -55K -110K -110K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-5.9M -5.9M -5.9M -5.9M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
17.25M 17.25M 17.25M 7.5M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a -11.01M -11.01M -11.01M -11.01M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
10.85M -590K -638K -10.06M -12.06M -1.72M -1.78M -1.75M -1.46M -361K -246K -155K n/a n/a n/a -55K -110K -110K
Debt Repayment
961K -16K n/a -473K -207K -207K -657K 266K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a 21K 21K 21K 21K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
15.34M 15.84M 16.42M -494K -709K -1.05M -595K -509K 30.39M 30.74M 30.77M 30.92M 440K 469K 496K 341K 280K -4M
Financial Cash Flow
2.02M 1.54M 16.44M 14.1M 14.4M 14.43M 414K 1.25M 31.62M 31.6M 31.33M 30.92M 2.31M 9.43M 23.78M 30.5M 30.85M 21.09M
Net Cash Flow
-8.86M -21.73M -8.9M -14.91M -16.77M -6.06M -19.5M -24.74M 5.81M 6.79M 17.72M 28.06M 2.52M 8.13M 13.05M 10.28M 11.24M 5.22M
Free Cash Flow
-22.22M -23.6M -25.68M -19.6M -20.16M -20.49M -19.91M -25.98M -25.81M -24.81M -13.61M -2.86M 204K -1.3M -10.73M -20.28M -19.72M -15.99M